View Article

  • Pharmacological Evaluation of Anti-inflammatory Activity of Nyctanthes arbor-tristis in Experimental Animal Models

  • Anuradha College of Pharmacy, chikhli, Anuradhanagar, sakegaon road, chikhali, Dist.Buldhana, Maharashtra (India)443201.

Abstract

Inflammation is a multifaceted physiological reaction driven by various chemical substances, including prostaglandins, cytokines, and nitric oxide [1,2]. While traditional anti-inflammatory medications are effective, their prolonged usage can lead to considerable adverse effects [3]. This study aimed to assess the anti-inflammatory properties of Nyctanthes arbor-tristis through experimental animal models. An ethanolic extract of the plant was obtained via Soxhlet extraction and underwent phytochemical analysis. The anti-inflammatory effects were evaluated using dextran-induced and formalin-induced paw edema models in mice. The extract was administered at dosages of 200 mg/kg and 400 mg/kg and was compared with the standard diclofenac at 10 mg/kg. Various parameters, including paw edema, locomotor activity, C-reactive protein levels, body weight, and feed intake, were measured. The findings indicated a significant dose-dependent decrease in inflammation, with the increased dosage demonstrating effects similar to those of the conventional medication. These results support the traditional application of Nyctanthes arbor-tristis and indicate its promise as a safer option for treating inflammatory conditions

Keywords

Nyctanthes arbor-tristis, Anti-inflammatory activity, Dextran-induced edema, Formalin model, Herbal medicine, CRP

Introduction

× Popup Image

Inflammation serves as the body's defense mechanism against harmful agents, including pathogens, damaged cells, or irritants. This response entails a series of intricate biochemical processes driven by inflammatory mediators like prostaglandins, leukotrienes, cytokines, and nitric oxide [1]. Acute inflammation is marked by the widening of blood vessels, heightened permeability of blood vessels, and the infiltration of white blood cells, while chronic inflammation is associated with tissue damage and the body's repair processes [10].

The activation of phospholipase A2 triggers the liberation of arachidonic acid, which is subsequently converted into prostaglandins and leukotrienes—essential mediators of inflammation. Nitric oxide (NO), generated by inducible nitric oxide synthase (iNOS), also significantly contributes to inflammatory processes.

Non-steroidal anti-inflammatory drugs (NSAIDs) like diclofenac function by blocking cyclooxygenase (COX) enzymes. Nonetheless, extended use of NSAIDs is linked to negative effects such as gastric ulcers, kidney damage, and cardiovascular issues. This has sparked a growing interest in plant-based alternatives that offer improved safety profiles.

Nyctanthes arbor-tristis, also known as Parijat, is a medicinal plant in the Oleaceae family. It is commonly employed in traditional medicine to treat inflammatory conditions like arthritis, fever, and joint pain [4,5]. Phytochemical analyses have identified the presence of iridoid glycosides, flavonoids, alkaloids, and tannins, which are recognized for their anti-inflammatory and antioxidant effects.

 Previous research indicates that the plant extract can inhibit inflammatory mediators such as TNF-α, IL-1β, and prostaglandins, as well as lower oxidative stress. Nonetheless, a thorough pharmacological assessment using standard experimental models is necessary to confirm its effectiveness. Therefore, the present study was designed to evaluate the anti-inflammatory activity of Nyctanthes arbor-tristis using dextran-induced and formalin-induced paw edema models in mice

 

 

Figure 1: Nyctanthes arbor-tristis

5. MATERIALS AND METHODS

5. 1. Experimental Animals

Healthy adult Manly mice (20 – 25 g) were used for the study. The creatures were housed under controlled environmental conditions (temperature 25 ± 1 °C, relative moisture 55 – 65, and 12- hour light/ dark cycle). Standard bullet diet and water were handed ad libitum.

All experimental procedures were carried out in agreement with guidelines of the CPCSEA and approved by the Institutional Animal Ethics Committee (IAEC blessing No. 751/ PO/ Re/ S/ 03/ CPCSEA/2026/1-1) (6).

5. 2. Plant Material and Authentication

The flowers of Nyctanthes dome- tristis were collected from original sources and authenticated by a good botanist from the institutional botany department. The factory material was gutted, shade- dried, and coarsely pulverized for farther processing.

5. 3. Preparation of Extract

The dried powdered factory material was subordinated to Soxhlet birth using 90 ethanol as detergent. The birth process was carried out for several cycles until complete birth was achieved. The attained excerpt was concentrated using a water bath and stored in a watertight vessel at room temperature for farther use.

 

 5. 4. Phytochemical Screening

Primary phytochemical webbing of the ethanolic excerpt was performed to descry the presence of colorful bioactive ingredients similar as flavonoids, alkaloids, tannins, phenolic composites, glycosides, and triterpenoids using standard qualitative tests. The presence of these ingredients was verified grounded on characteristic color changes and precipitate conformation.

5. 5. Acute Toxicity Study

Acute oral toxin study was conducted as per OECD guideline 425. The excerpt was set up to be safe at advanced boluses, and experimental boluses (200 mg/ kg and 400 mg/ kg) were named for pharmacological evaluation.

5. 6. Experimental Design

A total of 30 mice were divided into five groups (n = 6):

 

Table 1: Experimental design of animals

Group

Treatment

Group I

Normal control (0.5 mL normal saline)

Group II

Disease control

Group III

Standard (Diclofenac 10 mg/kg)

Group IV

Extract (200 mg/kg)

Group V

Extract (400 mg/kg)

 

5. 7. Induction of Inflammation

5. 7. A. Dextran-Induced Paw Edema

Acute inflammation was convinced by edging in 0.1 mL of 1 dextran result into the sub-plantar region of the right hind paw. Paw volume was measured at different time intervals (0,1, 2, and 3 hours). The increase in paw volume indicated the extent of inflammation (7,8).

5. 7. B. Formalin- Induced Paw Edema

Inflammation was convinced by edging in 0.1 mL of 2 formalin result into the paw. This model produces biphasic seditious response involving neurogenic and seditious intercessors. Paw edema was measured up to 4 hourspost-induction (7,8).

 5. 8. Evaluation Parameters

 5. 8.1 Paw Edema Measurement

 Paw volume was measured using a plethysmometer. The degree of inflammation was

 calculated as the increase in paw volume compared to birth.

% inhibition of edema was calculated using the formula:

%Inhibition = [1− (????????????????) /(????????????????)] ×100

Where:

 Vt= treated group

 Vc = control group

 Vd = disease group 

5. 8.2 Locomotor exertion

Locomotor exertion was assessed using a Rota- Rod outfit at 25 rpm with a cut- off time of 180 seconds. Reduction in locomotor exertion indicates inflammation- convinced discomfort, while enhancement suggests remedial effect.

 5. 8.3 C- Reactive Protein (CRP)

Blood samples were collected from the tail tone, and serum was separated by centrifugation.CRP situations were measured using ELISA accoutrements Elevated CRP situations indicate systemic inflammation.

 5. 8.4 Body Weight

Body weight was recorded ahead and after treatment. Reduction in body weight indicates complaint progression, while enhancement reflects remedial effect.

 5. 8.5 Feed Input

Feed input was measured daily. Reduced input is associated with inflammation, while normalization indicates recovery.

5. 9. Statistical Analysis

All data were expressed as mean ± SEM (n = 6). Statistical analysis was performed using one-

 way ANOVA followed by Duncan’s multiple range test. Values were considered statistically

 significant at * p< 0.05 and p< 0.01

6. Results

6.1 Phytochemical Screening

 

Table 02: Phytochemical constituents of ethanolic extract of Nyctanthes arbor-tristis

Phytochemical

Test

Observation

Inference

Flavonoids

Shinoda test

Pink/red color

Present

Flavonoids

Lead acetate

Yellow precipitate

Present

Alkaloids

Mayer’s test

Cream precipitate

Present

Alkaloids

Dragendorff’s test

Orange precipitate

Present

Phenols/Tannins

FeCl? test

Blue-green color

Present

Glycosides

Keller–Killiani

Brown ring

Present

 

6.2 Dextran-Induced Paw Edema

 

Table 03: Effect on paw edema (Dextran model)

Group

Paw Edema (ml) Mean ± SEM

% Inhibition

Control

0.60 ± 0.03

Disease

1.80 ± 0.08

0%

Standard (Diclofenac)

0.90 ± 0.04

50%

200 mg/kg

1.20 ± 0.06**

33%

400 mg/kg

0.95 ± 0.05*

47%

 

 

 

Figure 02: Effect of oral administration of ethanolic extract of Nyctanthes arbor-tristis on dextran induced paw edema in mice.

 

6.3 Formalin-Induced Paw Edema

 

Table 04: Effect on paw edema (Formalin model)

Group

Paw Edema (ml) Mean ± SEM

% Inhibition

Control

0.55 ± 0.03

Disease

2.10 ± 0.09

0%

Standard

1.00 ± 0.05

52%

200 mg/kg

1.40 ± 0.07**

33%

400 mg/kg

1.05 ± 0.06*

50%

 

 

 

Figure 03- Effect of oral administration of ethanolic extract of Nyctanthes arbor-tristis (EENAT) on formalin-induced paw edema in mice.

 

6.4 Locomotor Activity

 

Table 05: Locomotor activity (Dextran model)

Group

Locomotor Activity (sec)

Control

180 ± 0

Disease

111 ± 7

Standard

165 ± 3

200 mg/kg

151 ± 4**

400 mg/kg

161 ± 5*

 

 

 

Fig 04. Effect of oral administration of ethanolic extract of Nyctanthes arbor-tristis (EENAT) on Locomotor activity in Dextran-induced mice.

 

6.5 Locomotor Activity

 

Table 06: Locomotor activity (Formalin model)

Group

Locomotor Activity (sec)

Control

180 ± 0

Disease

102 ± 7

Standard

165 ± 4

200 mg/kg

150 ± 6**

400 mg/kg

160 ± 4*

 

 

Fig 05. Effect of oral administration of ethanolic extract of Nyctanthes arbor-tristis (EENAT) on Locomotor activity in Formalin-induced mice.

 

6.6 C-Reactive Protein (CRP)

 

Table 07: CRP levels (Dextran model)

Group

CRP (mg/dL)

Control

0.51 ± 0.08

Disease

2.87 ± 0.23

Standard

1.24 ± 0.15

200 mg/kg

1.67 ± 0.12**

400 mg/kg

1.46 ± 0.10*

 

 

Figure 06: Effect of oral administration of ethanolic extract of Nyctanthes arbor-tristis (EENAT) on C Reactive Proteins in Dextran-induced mice

 

6.7 C-Reactive Protein (CRP)

 

Table 08: CRP levels (Formaline model)

Group

Treatment

C reactive proteins

(mg/dL)

Control Group

No treatment

0.50 ± 0.08

Diseased Group

Formalin induced inflammation

2.85 ± 0.22

Standard

10 mg/kg Diclofenac

1.26 ± 0.14

200 mg/kg of EENAT

200mg/kg ethanolic extract of Nyctanthes arbor-tristis

1.69 ± 0.13**

400 mg/kg of EENAT

400mg/kg ethanolic extract of Nyctanthes arbor-tristis

1.49 ± 0.11*

 

 

Fig 07. Effect of oral administration of ethanolic extract of Nyctanthes arbor-tristis (EENAT) on C Reactive Proteins in Formalin-induced mice.

 

 

 

6.8 Body Weight

 

Table 09: Body weight (Dextran model)

Group

Initial

Final

% Change

Control

200 ± 10

219 ± 12

+10%

Disease

204 ± 8

196 ± 9

-4.9%

Standard

203 ± 7

211 ± 11

+3.4%

200 mg/kg

201 ± 9

209 ± 10

+3.0%

400 mg/kg

203 ± 8

216 ± 10

+5.4%

 

 

Fig 08: Effect of oral administration of ethanolic extract of Nyctanthes arbor-tristis (EENAT) on Body Weight in Dextran-induced mice.

 

6.9 Body Weight

 

Table 10: Body weight (Formaline model)

Group

Initial Weight

Final Weight

% Weight Change

Control Group

200 ± 8

229 ± 11

+15%

Diseased Group

197 ± 7

181 ± 9

-9.1%

Standard

198 ± 6

204 ± 9

+3.0%

200 mg/kg of EENAT

196 ± 5

201 ± 8**

+2.5%**

400 mg/kg of EENAT

200 ± 7

209 ± 10*

+4.5%*

 

 

Fig09. Effect of oral administration of ethanolic extract of Nyctanthes arbor-tristis (EENAT) on Body Weight in Formalin-induced mice.

 

6.10. Feed Intake

 

Table 12: Feed intake (Dextran model)

Group

Feed Intake (g)

Control

25.3 ± 0.7

Disease

18 ± 1.0

Standard

23.6 ± 0.8

200 mg/kg

22.4 ± 0.7

400 mg/kg

23.9 ± 0.9

 

 

Fig 10. Effect of oral administration of ethanolic extract of Nyctanthes arbor-tristis (EENAT) on Feed Intak in Dextran-induced mice.

 

6.11. Feed Intake

 

Table 13: Feed intake (Formaline model)

Group

Treatment

Feed Intake (gm)

Control Group

No treatment

25.2 ± 0.7

Diseased Group

Formalin induced inflammation

19.2 ± 1.0

Standard

10 mg/kg Diclofenac

23.2 ± 0.8

200 mg/kg of EENAT

200mg/kg ethanolic extract of Nyctanthes arbor-tristis

22.4 ± 0.7**

400 mg/kg of EENAT

400mg/kg ethanolic extract of Nyctanthes arbor-tristis

23.4 ± 0.9*

 

 

 

 

Fig 11. Effect of oral administration of ethanolic extract of Nyctanthes arbor-tristis (EENAT) on Feed Intake in Formalin-induced mice.

 

DISCUSSION

The present study demonstrates significantanti-inflammatory exertion of Nyctanthes arbor-   tristis in experimental models. The reduction in paw edema indicates inhibition of seditious intercessors similar as prostaglandins and cytokines (2).

The observed exertion may be attributed to the presence of flavonoids and iridoid glycosides, which are known to inhibit COX and LOX pathways (9). also, antioxidant parcels of the factory may contribute to reduced oxidative stress and inflammation.

The drop in CRP situations further supports theanti-inflammatory eventuality of the excerpt. enhancement in locomotor exertion indicates reduction in pain and inflammation (5).

The results are similar with standard medicine diclofenac, suggesting that the factory excerpt          may serve as an implicit volition with smaller side goods.

CONCLUSION

The study confirms that Nyctanthes dome- tristis possesses significantanti-inflammatory exertion in experimental models. The findings support its traditional use and highlight its eventuality as a natural remedial agent for seditious diseases. farther studies including clinical trials are recommended.

REFERENCES

  1. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008; 454:428–435.
  2. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011; 31:986–1000.
  3. Vane JR, Botting RM. Mechanism of action of NSAIDs. Am J Med. 1998; 104:2S–8S.
  4. Kirtikar KR, Basu BD. Indian Medicinal Plants. 2005.
  5. Gupta M, Mazumder UK. Anti-inflammatory activity of Nyctanthes arbor-tristis. Pharmacogn Mag. 2007.
  6. OECD. Acute Oral Toxicity Guidelines 425. 2008.
  7. Winter CA et al. Carrageenan-induced edema. Proc Soc Exp Biol Med. 1962.
  8. Vogel HG. Drug Discovery and Evaluation. Springer; 2002.
  9. Rang HP, Dale MM. Pharmacology. Elsevier; 2016.
  10. Kumar V, Abbas AK. Robbins Basic Pathology. Elsevier; 2018.
  11. Aktan F., (2004), iNOS-Mediated Nitric Oxide Production and Its Regulation, Life Sciences, pp. 639–653.
  12. Saha S., (2017), Phytochemical and Pharmacological Profile of Nyctanthes arbor-tristis, International Journal of Herbal Medicine, pp. 55–60.
  13. Katzung B.G., (2015), Basic and Clinical Pharmacology, McGraw-Hill, pp. 280–300.
  14. Pan S.Y., (2014), New Perspectives on Herbal Medicines in Inflammation, Evidence-Based Complementary and Alternative Medicine, pp. 1–10.
  15. Mukherjee P.K., (2012), Quality Control of Herbal Drugs, Business Horizons, pp. 150–165.
  16. Sharma P.C., (2015), Database on Medicinal Plants Used in Ayurveda, CCRAS Publication, pp. 320–322.
  17. Kirtikar K.R., Basu B.D., (2014), Indian Medicinal Plants, Vol. 3, International Book Distributors, pp. 1021–1023.
  18. Saha S., (2017), Phytochemical Profile of Nyctanthes arbor-tristis, International Journal of Herbal Medicine, pp. 55–60.
  19. Gupta R., (2019), Anti-inflammatory Mechanism of Herbal Plants, Journal of Natural Products, pp. 85–92.
  20. Singh A., (2020), Evaluation of Anti-inflammatory Activity of Nyctanthes arbor-tristis, Journal of Experimental Pharmacology, pp. 25–32.
  21. Mehta D., (2021), Pharmacological Activities of Parijat, Journal of Herbal Therapeutics, pp. 14–20.
  22. Verma S., (2018), Multi-targeted Herbal Drugs in Inflammation, Asian Journal of Pharmaceutical Sciences, pp. 60–68.
  23. Patil R., (2022), Experimental Models for Anti-inflammatory Screening, International Journal of Pharmacology, pp. 101–110.
  24. Halliwell B., (2007), Oxidative Stress and Inflammation, Biochemical Journal, pp. 1–12.
  25. Lobo V., (2010), Free Radicals, Antioxidants and Functional Foods, Pharmacognosy Reviews, pp. 118–126.
  26. Rahman I., (2006), Antioxidant Therapies in Inflammation, European Journal of Pharmacology, pp. 1–8.
  27. Saha S., (2017), Antioxidant Activity of Nyctanthes arbor-tristis, International Journal of Herbal Medicine, pp. 60–65.
  28. Tandon V., (2011), Iridoid Glycosides and Their Biological Activities, Phytochemistry, pp. 134–140.
  29. Singh S., (2015), Effect of Herbal Extracts on Cytokine Production, Journal of Ethnopharmacology, pp. 220–226.
  30. Vane J.R., (1998), Mechanism of Action of Anti-inflammatory Drugs, American Journal of Medicine, pp. 2–8.
  31. Gupta M., (2013), Experimental Evaluation of Anti-inflammatory Activity, Indian Journal of Pharmacology, pp. 250–255.
  32. Sharma R., (2016), Immunomodulatory Effects of Medicinal Plants, Journal of Herbal Medicine, pp. 75–82.
  33. OECD, (2001), Guidelines for Testing of Chemicals – Acute Oral Toxicity 423, OECD Publication, pp. 1–14.
  34. Patil S., (2020), Therapeutic Potential of Nyctanthes arbor-tristis, Journal of Pharmacognosy, pp. 90–96.
  35. Baldwin A.S., (2001), Control of Oncogenesis and Cancer Therapy Resistance by NF-κB, Journal of Clinical Investigation, pp. 241–246.
  36. Johnson G.L., (2002), Mitogen-Activated Protein Kinase Pathways, Science, pp. 1911–1912.

Reference

  1. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008; 454:428–435.
  2. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011; 31:986–1000.
  3. Vane JR, Botting RM. Mechanism of action of NSAIDs. Am J Med. 1998; 104:2S–8S.
  4. Kirtikar KR, Basu BD. Indian Medicinal Plants. 2005.
  5. Gupta M, Mazumder UK. Anti-inflammatory activity of Nyctanthes arbor-tristis. Pharmacogn Mag. 2007.
  6. OECD. Acute Oral Toxicity Guidelines 425. 2008.
  7. Winter CA et al. Carrageenan-induced edema. Proc Soc Exp Biol Med. 1962.
  8. Vogel HG. Drug Discovery and Evaluation. Springer; 2002.
  9. Rang HP, Dale MM. Pharmacology. Elsevier; 2016.
  10. Kumar V, Abbas AK. Robbins Basic Pathology. Elsevier; 2018.
  11. Aktan F., (2004), iNOS-Mediated Nitric Oxide Production and Its Regulation, Life Sciences, pp. 639–653.
  12. Saha S., (2017), Phytochemical and Pharmacological Profile of Nyctanthes arbor-tristis, International Journal of Herbal Medicine, pp. 55–60.
  13. Katzung B.G., (2015), Basic and Clinical Pharmacology, McGraw-Hill, pp. 280–300.
  14. Pan S.Y., (2014), New Perspectives on Herbal Medicines in Inflammation, Evidence-Based Complementary and Alternative Medicine, pp. 1–10.
  15. Mukherjee P.K., (2012), Quality Control of Herbal Drugs, Business Horizons, pp. 150–165.
  16. Sharma P.C., (2015), Database on Medicinal Plants Used in Ayurveda, CCRAS Publication, pp. 320–322.
  17. Kirtikar K.R., Basu B.D., (2014), Indian Medicinal Plants, Vol. 3, International Book Distributors, pp. 1021–1023.
  18. Saha S., (2017), Phytochemical Profile of Nyctanthes arbor-tristis, International Journal of Herbal Medicine, pp. 55–60.
  19. Gupta R., (2019), Anti-inflammatory Mechanism of Herbal Plants, Journal of Natural Products, pp. 85–92.
  20. Singh A., (2020), Evaluation of Anti-inflammatory Activity of Nyctanthes arbor-tristis, Journal of Experimental Pharmacology, pp. 25–32.
  21. Mehta D., (2021), Pharmacological Activities of Parijat, Journal of Herbal Therapeutics, pp. 14–20.
  22. Verma S., (2018), Multi-targeted Herbal Drugs in Inflammation, Asian Journal of Pharmaceutical Sciences, pp. 60–68.
  23. Patil R., (2022), Experimental Models for Anti-inflammatory Screening, International Journal of Pharmacology, pp. 101–110.
  24. Halliwell B., (2007), Oxidative Stress and Inflammation, Biochemical Journal, pp. 1–12.
  25. Lobo V., (2010), Free Radicals, Antioxidants and Functional Foods, Pharmacognosy Reviews, pp. 118–126.
  26. Rahman I., (2006), Antioxidant Therapies in Inflammation, European Journal of Pharmacology, pp. 1–8.
  27. Saha S., (2017), Antioxidant Activity of Nyctanthes arbor-tristis, International Journal of Herbal Medicine, pp. 60–65.
  28. Tandon V., (2011), Iridoid Glycosides and Their Biological Activities, Phytochemistry, pp. 134–140.
  29. Singh S., (2015), Effect of Herbal Extracts on Cytokine Production, Journal of Ethnopharmacology, pp. 220–226.
  30. Vane J.R., (1998), Mechanism of Action of Anti-inflammatory Drugs, American Journal of Medicine, pp. 2–8.
  31. Gupta M., (2013), Experimental Evaluation of Anti-inflammatory Activity, Indian Journal of Pharmacology, pp. 250–255.
  32. Sharma R., (2016), Immunomodulatory Effects of Medicinal Plants, Journal of Herbal Medicine, pp. 75–82.
  33. OECD, (2001), Guidelines for Testing of Chemicals – Acute Oral Toxicity 423, OECD Publication, pp. 1–14.
  34. Patil S., (2020), Therapeutic Potential of Nyctanthes arbor-tristis, Journal of Pharmacognosy, pp. 90–96.
  35. Baldwin A.S., (2001), Control of Oncogenesis and Cancer Therapy Resistance by NF-κB, Journal of Clinical Investigation, pp. 241–246.
  36. Johnson G.L., (2002), Mitogen-Activated Protein Kinase Pathways, Science, pp. 1911–1912.

Photo
Akanksha Kulthe
Corresponding author

Anuradha College of Pharmacy, chikhli, Anuradhanagar, sakegaon road, chikhali, Dist.Buldhana, Maharashtra (India)443201.

Photo
Dr. Kailash Biyani
Co-author

Anuradha College of Pharmacy, chikhli, Anuradhanagar, sakegaon road, chikhali, Dist.Buldhana, Maharashtra (India)443201.

Photo
Dr. Pavan Folane
Co-author

Anuradha College of Pharmacy, chikhli, Anuradhanagar, sakegaon road, chikhali, Dist.Buldhana, Maharashtra (India)443201.

Akanksha Kulthe, Dr. Kailash Biyani, Dr. Pavan Folane, Pharmacological Evaluation of Anti-inflammatory Activity of Nyctanthes arbor-tristis in Experimental Animal Models, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 5, 4345-4356, https://doi.org/10.5281/zenodo.20267248

More related articles
A Brief Review on Wedelia Chinensis (Osbeck) Merr...
Sharmili D, Mohamed Hussain N, Pachiyammal M, Tamilarasan R, B Ku...
Long-Term Melatonin Use: Benefits, Risks, And Clin...
Swaraj Mahanag, Dr. Anand Khode, Gauri Kshirsagar...
Related Articles
Formulation and Evaluation of a Sesame Oil-Based Foot Crack Cream for Wound Heal...
Sandhya khyamgonde , Avinash Hosmani, Laxmi Kawade, Sakshi Bhanap, Y.S. Thorat...
Application of natural modified starch as excipient for tailored pharmaceutical ...
Deepak Babu, Diksha Devi, Nita Yadav, Gaurav Kumar Chaurasia, Ritesh Kumar Tiwari...
A Brief Review on Wedelia Chinensis (Osbeck) Merr...
Sharmili D, Mohamed Hussain N, Pachiyammal M, Tamilarasan R, B Kumudhaveni, Vijaya Bharathi R, Muthu...
More related articles
A Brief Review on Wedelia Chinensis (Osbeck) Merr...
Sharmili D, Mohamed Hussain N, Pachiyammal M, Tamilarasan R, B Kumudhaveni, Vijaya Bharathi R, Muthu...
Long-Term Melatonin Use: Benefits, Risks, And Clinical Implications...
Swaraj Mahanag, Dr. Anand Khode, Gauri Kshirsagar...
A Brief Review on Wedelia Chinensis (Osbeck) Merr...
Sharmili D, Mohamed Hussain N, Pachiyammal M, Tamilarasan R, B Kumudhaveni, Vijaya Bharathi R, Muthu...
Long-Term Melatonin Use: Benefits, Risks, And Clinical Implications...
Swaraj Mahanag, Dr. Anand Khode, Gauri Kshirsagar...